Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients
Clinical trial NCT01941836 · COMPLETED
Trial details
- NCT number
- NCT01941836
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-10-01
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.